| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $70,659,980 ) (Continued on the next page) |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AI180075 | Treatment outcome requirements for disease prevention in Chagas disease | 000 | 3 | NIH | 6/25/2026 | $628,518 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01GM154846 | Heparan sulfate co-polymerase function and defects in disease | 000 | 3 | NIH | 7/14/2026 | $332,957 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM148240 | Platform for in vivo Metabolism | 001 | 4 | NIH | 2/26/2026 | $25,149 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM148240 | Platform for in vivo Metabolism | 000 | 4 | NIH | 2/20/2026 | $409,159 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01GM111939 | Structure and Function in alpha-Dystroglycan Glycosylation | 001 | 12 | NIH | 3/19/2026 | $37,769 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01GM111939 | Structure and Function in alpha-Dystroglycan Glycosylation | 000 | 12 | NIH | 1/21/2026 | $339,923 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM153268 | Epigenomic consequences of breakage-fusion-bridge cycling | 000 | 3 | NIH | 6/1/2026 | $368,444 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM150794 | Understanding inter-organellar communication in apicomplexan parasites | 000 | 4 | NIH | 7/23/2026 | $377,500 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01NS131659 | Developmental Programs as Vulnerabilities in H3.3G34-Mutant High-Grade Glioma | 000 | 3 | NIH | 8/11/2026 | $321,157 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | RC2DK140838 | The National Biorepository and Resource for Pituitary Neuroendocrine Tumor Translational Research (BioPitNeT) | 002 | 3 | NIH | 8/4/2026 | $2,697,340 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01HL173931 | Metabolic control of human endothelial development via the COUP-TF/1-deoxysphingosine axis | 000 | 3 | NIH | 5/13/2026 | $547,363 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AI173144 | Impacts of host lipid composition on antimicrobial susceptibilities of Staphylococcus aureus | 000 | 4 | NIH | 12/8/2025 | $477,462 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R33MH121560 | Cognitive Training for Emotion Regulation in Psychotic Disorders | 000 | 5 | NIH | 8/28/2026 | $549,411 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AI176776 | Synthesis and transport of outer membrane components across the Gram-negative cell envelope | 000 | 4 | NIH | 12/31/2025 | $640,850 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | K01AR082421 | Steps Towards OA Prevention | 001 | 4 | NIH | 8/6/2026 | $121,473 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01HL163256 | Effects of Early Life Exposure to Household Air Pollution on DNA Methylation and Respiratory Disease in Guatemalan Children from the Household Air Pollution Intervention Network (HAPIN) Trial | 001 | 4 | NIH | 8/4/2026 | $168,452 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01HL163256 | Effects of Early Life Exposure to Household Air Pollution on DNA Methylation and Respiratory Disease in Guatemalan Children from the Household Air Pollution Intervention Network (HAPIN) Trial | 000 | 4 | NIH | 5/27/2026 | $408,435 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01DA055630 | Early Adversity and Drug Use Vulnerability Among Low Income Rural Children: Testing a Neuro-ecological Model of Resilience | 001 | 4 | NIH | 2/11/2026 | $54,644 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01DA055630 | Early Adversity and Drug Use Vulnerability Among Low Income Rural Children: Testing a Neuro-ecological Model of Resilience | 000 | 4 | NIH | 2/5/2026 | $624,074 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AA026362 | The Neurokinin-1 Receptor as a Mediator of Alcoholism and Depression Comorbidity | 000 | 8 | NIH | 5/5/2026 | $340,622 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AI158743 | Synthetic multi-component influenza vaccines to elicit broad immunity | 000 | 3 | NIH | 1/6/2026 | $660,492 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01HD114750 | Mechanisms of uterine fluid absorption during early pregnancy | 000 | 3 | NIH | 3/24/2026 | $637,476 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM152057 | Regulation of protein transport in cilia | 001 | 3 | NIH | 3/23/2026 | $54,481 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21AI194190 | Cellular and molecular profiling of artemisinin-induced persister phenotypes in P. falciparum | 000 | 1 | NIH | 7/7/2026 | $436,750 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21MH142318 | Rural and Urban Differences in Social Media Use, Online Experiences, and Mental Health Among Socially Disconnected Adolescents | 000 | 1 | NIH | 8/18/2026 | $405,505 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21NS148841 | Extracellular Vesicle-Enhanced Mitochondrial Therapy for ALS and Neurodegeneration | 000 | 1 | NIH | 9/2/2026 | $402,347 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21AI202296 | Determining the relationship between parasite genetics and pathogen burden in Trypanosoma cruzi infected hosts | 000 | 1 | NIH | 9/3/2026 | $228,000 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21AI196824 | Identifying Plasmodium Liver-Stage Secreted Effector Proteins | 000 | 1 | NIH | 9/2/2026 | $190,000 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R56NS145513 | Sulfated Glycosaminoglycan Hydrogels for Treating Brain Volume Loss in TBI | 000 | 1 | NIH | 8/31/2026 | $506,968 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AG102730 | The TECHReserve Cohort Study: Technological Engagement for Cognitive Health and Reserve | 000 | 1 | NIH | 9/3/2026 | $750,765 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | K22AG088111 | Molecular Determinants of Age-Related Cognitive Decline in the Basal Forebrain to Lateral Entorhinal Cortex Circuit | 000 | 1 | NIH | 3/19/2026 | $198,352 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R00AI173531 | Separating late gene transcription from viral DNA replication in KSHV | 001 | 4 | NIH | 8/19/2026 | $242,200 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01DC023205 | Interactions between resident microbiota and invading middle ear pathogens | 000 | 1 | NIH | 9/1/2026 | $660,846 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R24AI201120 | Production and Distribution of Filarial Research Reagents | 000 | 1 | NIH | 9/1/2026 | $1,023,862 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21AI202814 | Parasite glycosylphosphatidylinositol Libraries: Expanding the Toolbox for Parasite Glycobiology | 000 | 1 | NIH | 7/3/2026 | $228,000 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01DE035487 | Engineered Synthetic Low-Density Lipoprotein Nanoparticles for Enhanced Cancer Immunotherapy in Head and Neck Cancer | 000 | 1 | NIH | 2/18/2026 | $644,452 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AI196741 | Novel approaches to predict strength and breadth of influenza vaccine response | 000 | 1 | NIH | 5/12/2026 | $805,866 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | F32AI202941 | Genomic regulation of transposon-mediated horizontal gene transfer in the fungal pathogen Aspergillus fumigatus | 000 | 1 | NIH | 8/10/2026 | $75,880 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AG093018 | Navigating the Journey to Middle Age in the SHAPE Study | 001 | 2 | NIH | 7/15/2026 | $647,837 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | RF1NS141022 | Neuroinflammatory Epitranscriptomic Mechanisms in Parkinson's Disease | 000 | 1 | NIH | 5/12/2026 | $1,297,188 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21AI202208 | Optimization of Antivirals Against Poxviruses | 000 | 1 | NIH | 8/25/2026 | $264,633 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | F31AI197783 | Elucidating the Role of the Naegleria fowleri secretome in a Host-Pathogen Context | 001 | 1 | NIH | 7/28/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | F31AI197783 | Elucidating the Role of the Naegleria fowleri secretome in a Host-Pathogen Context | 000 | 1 | NIH | 7/28/2026 | $50,114 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AI195646 | Molecular analysis of transcription termination by RNA polymerase II in trypanosomatids | 000 | 1 | NIH | 8/7/2026 | $675,790 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01DA067308 | Integrated Biomedical-Behavioral HIV Prevention for Women in Non-carceral Correctional Supervision Programs: A Hybrid Type II Trial of E-WORTH South in Alabama | 000 | 1 | NIH | 8/17/2026 | $608,658 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | F31AI197675 | Interorganellar communication and dynamics in the divergent eukaryotic parasite Toxoplasma gondii | 001 | 1 | NIH | 8/5/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | F31AI197675 | Interorganellar communication and dynamics in the divergent eukaryotic parasite Toxoplasma gondii | 000 | 1 | NIH | 8/5/2026 | $50,114 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01CA304246 | Modeling Bone Breast Tumor Cell Interactions to Predict and Prevent Metastasis | 000 | 1 | NIH | 8/12/2026 | $479,860 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01GM164352 | Somatic and germline fate decisions in dynamic stem cell utilization by tapeworms | 000 | 1 | NIH | 8/6/2026 | $442,250 |
|
